Our study describes, for the first time, the regulatory effect of SIRT4 on GDH enzyme activity in HSCs and demonstrates that SIRT4 inhibits glutamine metabolism in HSCs in a mechanism similar to that of tumor metabolic reprogramming and plays an antifibrotic role. The gene discussed is SIRT4; the disease is neoplasm.